Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18338904 | 1.00 | ALDH1A1 (0.42) | ALDH1A1PTPN1 | |
| SCHEMBL13409665 | 1.00 | ALDH1A1 (0.42) | ALDH1A1PTPN1 | |
| SCHEMBL13409660 | 1.00 | ALDH1A1 (0.42) | ALDH1A1PTPN1 | |
| SCHEMBL18338905 | 1.00 | ALDH1A1 (0.42) | ALDH1A1PTPN1 | |
| SCHEMBL13409670 | 1.00 | ALDH1A1 (0.42) | ALDH1A1PTPN1 | |
| SCHEMBL9209297 | 0.79 | MEN1 (0.35) | ALDH1A1PTPN1 | |
| SCHEMBL2987624 | 0.74 | MEN1 (0.42) | ALDH1A1PTPN1 | |
| SCHEMBL13949345 | 0.74 | MEN1 (0.42) | ALDH1A1PTPN1 | |
| SCHEMBL2987618 | 0.74 | MEN1 (0.42) | ALDH1A1PTPN1 | |
| SCHEMBL13949348 | 0.74 | MEN1 (0.42) | ALDH1A1PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7704941-B2 | Citral derivatives | FLEXITRAL, INC. (US) | 2010-04-27 | — | — | US | disclosed |
| US-7704941-B2 | Citral derivatives | FLEXITRAL, INC. (US) | 2010-04-27 | — | — | US | disclosed |
| US-20080015136-A1 | CITRAL DERIVATIVES | FLEXITRAL, INC. (US) | 2008-01-17 | — | — | US | disclosed |
| US-20080015136-A1 | CITRAL DERIVATIVES | FLEXITRAL, INC. (US) | 2008-01-17 | — | — | US | disclosed |
| US-7309795-B2 | Citral derivatives | FLEXITRAL, INC. | 2007-12-18 | — | — | US | disclosed |
| US-7309795-B2 | Citral derivatives | FLEXITRAL, INC. | 2007-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080015136-A1 | CITRAL DERIVATIVES | TAS2R5, TAS2R7, TAS2R8 | ALDH1A1 234/4885PTPN1 4551/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.